The XEN GEL Implant (Allergan Inc., CA, USA) is an FDA approved implant that is inserted into the eye to connect the inner eye fluid with the outside area under the conjunctival. It has a 6-mm hydrophilic tube of collagen-derived gelatin cross-linked with glutaraldehyde. It has with a 45micron internal diameter and an external diameter that expands […]
Researchers in Italy reported two patients with glaucoma who used Cord Blood Serum and improved their Mean Deviation and Pattern Standard Deviation scores on visual fields, which is a key way to determine progression of glaucoma. This would be amazing if true. The key confounders are: 1. super small sample size of 2, and 2. Cord
Spiriva for COPD can theoretically cause angle closure glaucoma in narrow angle patients, but risk likely low.
There is 1 case report of Tiotropium (ingredient in SPIRIVA) causing acute angle closure glaucoma. If you have narrow angles of eye, let PCP know. Otherwise rare risk of cataract. No case reports of macular degeneration. Pulm Pharmacol Ther. 2007;20(6):627-8. Epub 2006 Aug 18. Acute angle-closure glaucoma precipitated by local tiotropium absorption. Oksuz H1, Tamer C, Akoglu S, Duru M. Author information Abstract
The holy grail of glaucoma care is continuous intraocular pressure monitoring! This helps the eyeMD and patient have all the facts to know if their eye pressure is too high or just right. The below innovation, if it turns out to have a high sensitivity and specificity (ie how much is it affected by rubbing
https://docs.google.com/document/d/1Ph9T5CJ91b_Su0cSe6Is-Ih9fbOnLHWVczfKgqms7Cw/pub Tiered Approach to Treating GLAUCOMA My goal is to help you optimize your vision at all times and help you understand your diagnosis. It can be scary if your I or any eyeMD says you are a suspect for glaucoma or that you have glaucoma. In general Glaucoma is a disease that damages the
New Glaucoma Drop: A combination of Alphagan (brimonidine) and Carbonic Anhydrase inhibitor (like Trusopt: brinzolamide) Called Simbrinza
Simbrinza is a combination of brimonidine and brinzolamide. 1. It was FDA approved this week. 2. It is the only beta blocker–free, fixed-combination therapy for glaucoma available in the United States. 3. Simbrinza combines a carbonic anhydrase inhibitor (brinzolamide 1.0%) and an alpha 2 adrenergic receptor agonist (brimonidine tartrate 0.2%) in a single multidose bottle 4. For